The amount and variety of new psychoactive substances (NPS) are expanding, and there are difficulties in assessing their risks. In this regard, in silico methods are potentially useful to predict NPS properties faster and at a lower cost. In this work a quantitative structure-activity relationship (QSAR) model was used to verify the risk of drugs derived from amphetamines and cathinones. A dataset of 26 derivatives with in vitro affinity for norepinephrine transporter (NET) was selected. To ensure reproducibility of the results, only geometric molecular descriptors (AM1 (Austin model 1) level) obtained from the platform ChemDes and ordered predictors selection (OPS) were used. The model presents good internal statistics (n = 23; coefficient of determination (R 2 ) = 0.914). The small number of samples was divided into seven training sets (n = 17) and seven test sets (n = 6). The average R 2 pred = 0.754 showed that the model has good predictive capacity. Based on the tests, this model can accurately predict the risk range of three previously selected derivatives: methedrone (low), ethcathinone (medium), and methamphetamine (high), even when only data referring to NET are employed. We used these data to create a simple free program in Java that focuses on the risk assessment of recreational drugs belonging to this class of compounds.
Introduction
United Nations Office on Drugs and Crime (UNODC) reported the occurrence of more than 800 new psychoactive substances (NPS) until 2017. 1 This phenomenon consists of producing NPS from prohibited substances, which makes the detection of new drugs difficult and renders enforcement ineffective. 1 These new substances are denominated bath salts, legal highs, or designer drugs among other designations. 2 The NPS market is characterized by a dynamics involving the appearance of new substances bearing different chemical groups. 3 In recent years, hundreds of NPS have been informed. In 2016, the amount of seized amphetamine-type stimulants (ATS) reached a record level: it went up from 205 tons in 2015 to 247 tons.
Knowledge about the health damage caused by using NPS is increasing. 4 As NPS become more available and diverse, more reports of damage and fatalities emerge. The rate at which these substances proliferate poses risks to the public health and to drug policies. The UNODC considers that a drug is harmful when the user's physical or mental health is compromised. Very little is known about the adverse health and social effects of NPS, which hinders prevention and treatment mechanisms. In 2016, about 275 million people aged between 15 and 64 were counted as drug users worldwide; 31 million people suffer some disorder due to harmful drug use and may need treatment. 5 Regarding users' behavior, use of multiple NPS is common, and these substances may also be consumed in combination with conventional drugs. This situation presents challenges to professionals handling health emergencies and treating people with drug use disorders. 5 While experienced drug users are usually concerned about the composition, dosage, and effects of the drugs they consume, younger users are less aware.
Effective drug combat requires monitoring, information sharing, and risk awareness. However, no information about the behavior of these substances (such as their toxicity and carcinogenic potential) or their composition is available, which leads to uncertainties about their characterization and the damages caused by their use. 1 This lack of information limits understanding of their long-term effects and risks and poses new challenges to their prevention and/or prohibition. 4, [6] [7] [8] [9] [10] [11] If available, all this information could be used in harm reduction strategies that could help to mitigate the negative consequences of drug use.
The use of stimulant drugs has grown, and healthy people have consumed a number of NPS to boost their cognitive function and creativity or simply for pleasure and motivation. However, users have to be made aware of the serious adverse health events associated with these substances. To make matters worse, the way NPS affect the physical and mental health in the long term is still being investigated. 12 Different guidelines [13] [14] [15] have driven NPS risk assessment studies. Regardless of the approach, information about NPS pharmacology, toxicology, dependence potential, and other technical data are required. Cases of clinical intoxication and pharmacological and toxicological data are largely non-existent. 16, 17 Risk assessment procedures can take long time and demand a lot of scientific data. Increased onset and NPS types as well as lack of toxicological/pharmacological data constitute challenges for risk assessment procedures. Regulating these NPS is important, and knowledge about their potential toxic behavior is required. 18 Although some studies of amphetamine and cathinone ( Figure 1 ) derivatives exist, [19] [20] [21] [22] [23] [24] [25] they only cover a few compounds and apply distinct methodologies, which makes data evaluation difficult. 24, [26] [27] [28] In this sense, in vitro studies are an essential strategy to understand NPS pharmacological behavior and the resulting clinical and toxicological effects.
Monoamine transporters can absorb neurotransmitters, which are unbound compounds in extracellular space. Many pharmacological agents that affect brain function target these transporters, like psychostimulants, antidepressants, and neurotoxins. 16, 17 Monoamine transporters like NET, DAT, and SERT underlie norepinephrine (NE), dopamine (DA), and serotonin (5-HT) reuptake, respectively. NET, DAT, and SERT interact with NPS, which acts as a transporter blocker reuptake, providing high presynaptic release. 29 Here, we have studied one of these transporters, namely NET. When amphetamine-type drugs interact with NET, the transporter function is interrupted, which raises the extracellular monoamine concentrations and causes many harmful effects. [30] [31] [32] Theoretical chemistry can help to determine molecular properties accurately. Constant computer development and more sophisticated methods allow problems to be overcome. 33 Despite the importance of experimental methods for toxicological evaluation, traditional methods can demand a great amount of time and involve high costs and large use of animals 34 due to the great number of known chemicals. In this context, in silico methods are extremely useful: they demand shorter time to determine drug toxicity, which enable researchers to keep pace with the constant appearance of new drugs. [35] [36] [37] [38] [39] In addition, apart from toxicity prediction, understanding how structural variation is related to the toxic potential of a compound is crucial. 40 Computational tools have been used to verify whether it is possible to create a model to correlate structure and property. Quantitative structure-activity/property relationship [QSA(P)R] methods consist in formulating mathematical models to understand how structural, electronic, and steric parameters, among others, explain the investigated property. QSAR models have application restricted to a group of molecules with structural similarity. Because QSAR models are reductionist models, they can only be trusted for structures that are contemplated in the employed dataset. [41] [42] [43] [44] These methods have great potential in the forensic field. This is particularly true for studies of amphetamines and cathinones, which are a very important class of NPS. Theoretical studies of these compounds are rare even for non-forensic interests. [45] [46] [47] [48] [49] [50] [51] [52] [53] There are also few QSAR studies involving these molecules. 28, [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] In view of this scenario, the present study has sought to obtain a QSAR model that can assess the potential risk of amphetamine-type substances on the basis of the common structure of amphetamines and cathinones. To evaluate this possibility, we have studied a set of 26 derivatives with in vitro measured activity against NET. 24, 25 This study can provide insights into how these drugs behave and may inspire new in silico studies that will help to understand how modifications in the substances can affect their ability to inhibit monoamine transporters. Biochemical studies have shown that simple changes in the chemical structure of these compounds can significantly impact their selectivity toward substrates, consequently inducing the release of different monoamine neurotransmitters and altering the NPS harmful potential. 66, 67 NPS inhibit the monoamine transporter function to different extents. The potency of inhibition (IC 50 , half maximal inhibitory concentration) of NET and DAT by NPS is related to the psychostimulant effects and enhances an individual's susceptibility to abuse. 24 Cytotoxicity determinations related to acute median lethal dose (LD 50 ) toxicity may represent an alternative strategy to toxicological testing in animals. [68] [69] [70] [71] Some studies have used lethality indexes (LI = IC 50 / LD 50 ) to predict how LD 50 and IC 50 are correlated. 70, 72 Various literature reports 70, [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] have used cytotoxicity values to estimate acute toxicity.
The present study was performed according to the criteria of the Organization for Economic Co-Operation and Development (OECD) 91 for the validation of structureactivity/property models. This study was designed so that it can be easily reproduced and applied.
Experimental
The OECD principles
The OECD 91 defines five criteria that must be followed to validate QSA(P)R models so that they generate predictions with a minimum level of reliability, and so that they are suitable for use, especially for regulatory use, as described in the registration, evaluation, authorization, and restriction of chemicals (REACH). These guidelines recommend that a model must have a defined endpoint, an unambiguous algorithm, a defined applicability domain, appropriate measures of goodness-of-fit, robustness, and predictability, and a mechanistic interpretation, if possible. 91 Considering these objectives, our models were constructed to follow these indications in the best possible way. One of our main concerns was to ensure that any reader of this study could be able to reproduce the results and use the models presented in their own studies. For this reason, only free programs have been used.
Dataset and molecular descriptors
A dataset with 26 amphetamine and cathinone derivatives ( Table 1 ) was obtained from the literature. 24, 25 The SMILES (simplified molecular input line entry system) strings 92 of all compounds were obtained from their 2D structures in the ACD/ChemSketch 12.0. 93 The endpoint was the concentration (µM) that was necessary to inhibit NET by 50% (IC 50 ).
To ensure greater reliability of the results and compliance of the study with the OECD principle No. 1, data from studies 91,92 using the same biological assay methodology was used for all the selected compounds. These values were converted to their respective pIC 50 (−log IC 50 ); this procedure is standard in QSAR and guarantees a more homogeneous distribution of the values of the dependent variable y.
Next, each SMILES string was used in the ChemDes 94 to calculate molecular descriptors. This server is a free tool and its use guarantees both the reproducibility of the study and the use of the models obtained by interested users (important information to meet the OECD principle No. 2). 91 The strings were used to generate 612 geometric descriptors [from the 3D-MoRSE (3D-molecule representation of structures based on electron diffraction), WHIM (weighted holistic invariant molecular descriptors), RDF (radial distribution function), and CPSA (charged partial surface area) classes]; a tool on the same server was used to build and to optimize the geometries at the AM1 (Austin Model 1) semiempirical level. This class of descriptors was selected because preliminary tests showed that the best predictive models could be obtained with their use. Despite the availability of the AM1 method, electronic descriptors are not available in the mentioned server, so they were not obtained in another program to achieve the OECD principle No. 2.
Variable selection
A variable reduction step was performed by visual observation of the data matrix to eliminate: (i) invariant or quasi-invariant descriptors (i.e., only one or two samples presented different values from the others); (ii) those descriptors that had a standard deviation less than or equal to 0.001, probably because they had little information that was relevant to the construction of a quantitative model; and (iii) descriptors with absolute Pearson's correlation coefficient (|r|) with dependent variable lower than 0.2, to remove those descriptors that presented numerical variability irrelevant with the endpoint in the study.
At the end of this step, a matrix with 265 molecular descriptors was obtained, which was then used to select variables with the OPS (ordered predictors selection) method. 95 This method was implemented in the QSAR modeling 96 (and also as free MATLAB tool in the same site) to define which was the best set of descriptors to generate the desired models. Given that the different descriptors and the biological activity showed ranges of numerical variation, 97 both were autoscaled (columnwise mean-centered and scaled to unity variance) prior to chemometric analysis. The models were built by using the partial least squares (PLS) regression method, 98 and the existence of outliers (i.e., samples with anomalous behavior that impair the quality of the model) was verified by analyzing the graph of studentized residuals versus leverages obtained in the cross-validation process. 99 
Model validation
Validation is essential for a QSAR model, and its implementation is necessary to obey the OECD principle No. 3. The suitability of the models to the minimum parameters required was assessed on the basis of their coefficient of determination (R 2 ) and root mean squared error calibration (RMSEC), the F-ratio test with 95% confidence interval (F, α = 0.05), Q 2 LOO (coefficient of determination of cross-validation), and root mean squared error cross validation (RMSECV). The RmSquare metrics related to cross validation were also used: average r m 2 (LOO)-scaled and ∆r m 2 (LOO)-scaled (leave one out). 100 LNO (leave N-out) cross-validation test, where N ranges from 1 to 5 for all the models, and each N was repeated six times (in each replicate, the data matrix rows were randomized), was used to verify the robustness of the model. For a robust model, an average Q 2 LNO was expected to be close to Q 2 LOO . 97 To test for the presence of chance correlation, the y-randomization test was carried out. For this test, the vector y, which is biological activity, was scrambled 40 times to verify the presence or absence of spurious correlations. 97 The intercepts of correlations between the original vector and each randomized vector must be less than 0.3 for R 2 and less than 0.05 for Q 2 LOO . These tests were carried out in QSAR modeling, except for the RmSquare metrics, which were obtained through XternalValidation Metric Calculator, 101 which is also a free software.
For external validation, 102 an alternative approach, based on de Campos and de Melo, 103 and on Birck et al., 104 was adopted. The auxiliary model 97 was divided into seven different training and test sets, all composed of 17 (74%) and 6 (26%) compounds, respectively. This division was made with the Dataset Division 1.2 105 software and was obtained on the basis of the Euclidian distance (three sets), activity/property algorithm (three sets), and Kennard-Stone algorithm (one set). These new models were evaluated according to their ability to predict each sample of each test set, taking the average values of parameters commonly used in external validation into account: (i) R 2 pred (coefficient of determination of external validation); (ii) root mean square error of prediction (RMSEP); (iii) k and k' (Golbraikh-Tropsha slopes of the linear regression lines between the observed and the predicted activities in the external validation); (iv) |R 2 0 − R 2 ' 0 | (Golbraikh-Tropsha absolute values of the difference between the coefficients of multiple determination); and (v) ∆r m 2 (pred)-scaled, and average r m 2 (pred)-scaled. 100, 102, 106, 107 These tests provide the best means of ensuring maximum model reliability, quality, and efficiency.
Two complementary tests were performed. First, three compounds were selected from the same references: little active (methedrone), medium active (ethcathinone), and very active (methamphetamine). These three compounds were also evaluated for their suitability to the model according to the applicability domain 108 by means of the Euclidean Applicability Domain 1.0 software. 109 The applicability domain fitting test intends to meet the OECD principle No. 4. The second test involved the use of the tool prediction reliable indicator recently proposed by Roy et al. 110 For this test, compounds with the structures resembling the structure of amphetamines and cathinones ( Figure 1) were investigated in the Drug Bank 111 on the basis of a 0.7 similarity threshold. The use of these criteria provided 18 results. Excluding duplicated results and results that were already part of the dataset, 11 compounds remained for evaluation. These compounds, 27 to 37 (Figure 2) , were referred to as real external set. For the test, the standard weighting scheme 0.5-0-0.5 was employed.
Results and Discussion
In QSAR studies, the variable selection step is designed to find the best subset of independent variables (i.e., Figure 2 . Real external set obtained in the Drug Bank data bank. 111 molecular descriptors) that will allow the most appropriate model to be constructed, so that the response variable under study can be predicted. 112 Among the available approaches, the OPS method has provided excellent results both in structure-activity studies 95, 96 and in the treatment of data from other chemometric problems. 113, 114 The PLS regression method 98 reconstructs the original variables into latent variables (LVs) that are orthogonal to each other, solving problems arising from a high correlation between the original variables; the models are constructed by using only really relevant information to describe the response variable. Based on these considerations, we concluded that the prediction model obtained herein (equation 1) consisted of three LVs that accumulate 63.877% of the original information (LV1: 25.628%, LV2: 20.276%, and LV3: 17.974%). Table 2 shows the model composed of seven molecular descriptors. We considered all 23 samples in the modeling because we did not identify any outliers. This was important because the original structural representativeness of the dataset was not impaired, and also because we separated compounds 24, 25, and 26 for further testing. The model presented R 2 of 0.914, i.e., it properly explained 91.4% of the information, which was well above the recommended minimum (R 2 > 0.6). This result was reflected in the low value of its associated RMSEC because it represented the variability in unexplained activity of the model. The model was also significant: the result obtained for its F test (confidence of 95%, α = 0.05) was greater than its critical value (cF = 3.127, for p = 3 and n-p-1 = 19). The internal predictability, evaluated through LOO crossvalidation, showed that the model was able to predict 83.5% of the information, which was also well above the recommended value for coefficient of determination of cross-validation (Q 2 LOO > 0.5); the associate RMSECV was also low. The difference between the values of R 2 and Q 2 LOO was only 0.079, which virtually excluded the possibility that the model presented data overfitting. 97, 115 The results of the LNO test 97 (Figure 3a ) showed that the model was robust, since its average value (Q 2 LNO = 0.823) was only 0.012 units below the Q 2 LOO value, and the greatest fluctuation in the Q 2 L6O results was only 0.06. Finally, the results for the y-randomization test 115 (Figure 3b ) indicated that the model was free from chance correlation because the obtained correlation lines had intercepts within the recommended limits.
Although the model was approved in the internal validation statistics, it was still necessary to approve its external validation. [99] [100] [101] [102] 107 A QSA(P)R model is normally designed to predict medicinal (potency and pharmacokinetics of new pharmaceuticals, or their toxic effects), environmental (ecotoxicity and fate), and other (development of new agrochemicals, flavors, food ingredients, surfactants, etc.) [116] [117] [118] endpoints. It can also be used for regulatory purposes: a properly used model can predict whether a new chemical can be harmful to people and the environment even without the use of experimental techniques, so the registration of a chemical can be denied or sought, or new safety instructions can be deferred. 91, 118 Many literature examples 36, [119] [120] [121] [122] [123] [124] [125] [126] have shown how these methods are associated with regulatory issues. Mechanism of action experimental determination is time-consuming and expensive. Methods that avoid tests in animals are also highly desirable. Unfortunately, experimental studies cannot be performed as fast as new NPS emerge. In this sense, the central idea of our study was to predict how these substances behave. In this scenario, in silico calculations can be a useful and less expensive tool to predict drug behavior and to avoid tests in animals, but it does not dismiss risk assessment. Because the risk posed by these drugs is largely unknown, in silico information can help to predict inhibition data faster, thereby revealing trends and constituting an alternative strategy to obtain prompt information to drive legal issues. 1, 71, 127 In this context, external validation, when the predictive capacity of the model is evaluated by using a set of compounds that were not used to construct the model, is a crucial step. 107 In general, the original dataset is divided into training set and test set. The first set is used to construct the model, whereas the second set is used for the external validation. However, an important step in our study was to assess risk without losing the structural information encoded in the model. Losing such information would undermine the future application of the model to new synthetic cathinone and amphetamine derivatives. Thus, we adopted an alternative approach: 103, 104 we divided model 1 (or the auxiliary model) 33 into seven different training and test sets, which consisted of 17 (74%) and 6 (26%) compounds, respectively. Therefore, after we accomplished predictions for each sample of each test set, we conducted the external validation. Table 3 summarizes the mean results. The values were within the ranges recommended by the literature. As for the individual values, only one of the sets obtained with the activity/property algorithm presented a value outside the limit (∆r m 2 (pred)-scaled = 0.212); nevertheless, this value was only 0.012 over the recommended limit. These results indicated that the quality of the external prediction of the model was adequate. In conclusion, the data were robust enough to construct model 1: only one (around 2%) out of 49 tests was slightly above the recommended limit.
We predicted the pIC 50 (−log IC 50 ) values of three previously selected derivatives (24, 25, and 26) of the same references to verify the potential of the model. Although the IC 50 values of these compounds were available (Table 2) , this prediction step aimed to verify the following points: (i) whether the values predicted for each compound were located within the linear range of the model, where the predictions were due to interpolation; (ii) whether each value was predicted in the regions where the pIC 50 of each value was located, i.e., low, medium, and high activity range for methedrone, ethcathinone, and methamphetamine, respectively. In this case, we expected to use this model to determine the degree of risk of any new NPS in relation to the compounds used to construct the model. The idea was that, even if experimental methods could not predict the model, there would be a faster way to obtain a value for risk assessment; and (iii) whether each of the three selected compounds were framed in the applicability domain (AD) of the model. This test can be defined as the chemical space from which a model is derived and where a prediction is considered to be reliable. 108 Because we designed this study to use the model for NPS for which IC 50 values have not been described, we used the Euclidean AD. This approach was based exclusively on the degree of structural similarity of the test compounds in relation to the compounds we used to construct the real model. We made the comparison through molecular descriptors, and the use of endpoint values for comparison purposes was dismissed.
The model predicted the following pIC 50 values: 5.427 for methedrone, 6.445 for ethcathinone, and 7.109 for methamphetamine. The aforementioned predicted values were within the real range of activity of each substance. The AD test (Figure 4) showed that model 1 suitably represented the three compounds. Therefore, the model can predict the interaction between NET and other derivatives that have the basic structure of amphetamines and cathinones, that is, it can potentially determine the risk of new designer drugs belonging to these classes of compounds.
The second test employed the Prediction Reliable Indicator tool. 110 We designed it to verify the level of applicability of the obtained model to compounds that had similar structure to the structure of the original dataset, but which at no time were part of the collected dataset. To our knowledge, none of the selected compounds, which were all derived from amphetamines and cathinones, had their biological activity determined by the methodology used during the studies from which the dataset was obtained. 19, 128 The results of a real external set ( Figure 4 ) extracted from Drug Bank 111 showed that all compounds were in the AD defined for the training set, as seen from the normalized mean distance values ( Table 4 ). The AD approach was perfectly applied to this set and had the same objectives as the first test ( Figure 4) . As in the case of compounds 24 to 26, we calculated molecular descriptors in the ChemDes web server. 94 The predictions were all classified as moderate (also in Table 4 ). This new approach corresponded to a quality assessment of the model regarding new query chemicals that were not part of the modeling. It was possible to evaluate the new query chemicals and to categorize the quality of predictions into good, moderate, and poor/ unreliable according to a composite score. We computed this composite score by using three individual scores: the score based on the quality of LOO predictions of the 10 training compounds closest to a test/external compound; the score based on the similarity-based AD obtained by using the standardization method; and the score based on the proximity of predictions to the training set observed/ experimental mean response.
The OECD principle No. 5 recommends a mechanistic interpretation, if possible. If this interpretation is consistent with information previously available on the action mechanism of the molecule under study, the obtained model is considered to be more reliable. However, if the model has been fully statistically validated, it can be used for predictive purposes even if a mechanistic interpretation is not possible. 102, 129 Given the objectives of this work, we did not need to consider the last guideline in this study. Nevertheless, it was interesting to observe the information that could be encoded in the selected descriptors ( Table 5 ). All the descriptors can be classified as geometric descriptors; that is, they are obtained from the three-dimensional structures of each molecule. We used this class of descriptors because preliminary studies with other classes of descriptors available in the webserver ChemDes 94 did not lead to models with adequate predictability (results not shown). Several categories of geometric descriptors exist, such as 3D-MoRSE, RDF, and WHIM. 112 In general, these descriptors encode different information on the importance of molecular geometry for the endpoint under study and their influence on its variation (positive or negative). Considering only the absolute and autoscaled value of each descriptor (Table 5) , the order of importance for the prediction of the endpoint is MoRSEE25 > MoRSEE4 > Only P2u is purely geometric (unweight). Therefore, we evaluated the electronic and geometric aspects that are most important for blocking the NET receptor.
To facilitate the use of the model to determine the risk of new NPS derived from amphetamines and cathinones, we developed a program to apply the model and to calculate the values of pIC 50 and their corresponding IC 50 (in µM) ( Figure 2 ). The program ( Figure 5 ), which is available for download, 130 was written by using the Java programming language, version 8.0, 131 and it can be run under any operating system if the Java Virtual Machine (JRE) is installed. The user must provide the values of the calculated descriptors that are part of the model, and the program then calculates the pIC 50 and IC 50 values on the basis of the provided values. For this purpose, the model descriptors must be calculated on the ChemDes server 94 with the corresponding SMILES string. Nevertheless, it is important to remember that the dataset only includes two structural classes, amphetamine and cathinone derivatives, so the model is only applicable to amphetamine and cathinone derivatives and to compounds having the basic structure shown in Figure 1 . In addition, the user should determine whether the compound to be tested is in the model applicability domain. This determination can be made by using Table 3 as the training set descriptors and the values calculated for the test compound as a test set; all the set can be applied in the Euclidean Applicability Domain 1.0 program. 109 The prediction will present minimum reliability only if the normalized value is less than or equal to 1.
Conclusions
We have presented the results of a QSAR study based on the ability of a set of amphetamine and cathinone derivatives to inhibit NET, which is one of the biological targets of this class of NPS. NET stimulation with these NPS culminates in diverse toxic effects and addiction. The model obtained here meets all the OECD criteria for the validation of prediction models. The speed at which these new abuse substances emerge is cause for concern because information about how they affect the human organism is scarce. The use of in silico methods, developed on the basis of known compounds, may aid risk assessment of new derivatives only on the basis of their chemical structures. The model presents excellent fit, as well as internal and external prediction power. According to the performance during LNO cross-validation, the model is robust. The y-randomization shows that the model does not present chance correlation. Besides showing the prediction quality of the model, the external validation approach used herein reinforces the model robustness. A first test conducted with three previously selected derivatives indicates that the model can predict the low, medium, and high-power ranges into which each compound fits. The applicability domain test performed with the three selected derivatives attests that the structures are adequately represented by the chemical space of the model. If the activity forecast ranges can be considered reliable, the model can be used for forensic purposes. The test performed with the new tool Prediction Reliability Indicator indicates that the model is reliable enough to predict NET inhibition by compounds resembling amphetamines and cathinones. The results of this study demonstrate that in silico tools can be potentially useful in the risk assessment of new psychoactive substances.
